Ascribe Bio
PrivateLast Round
Series A
Oct 14, 2025
Total Funding Raised
$12.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ascribe Bio is an agricultural technology company that develops natural crop protection solutions derived from small molecules found in the soil microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascribe Bio Comparables
Compare Ascribe Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innatrix, Inc. | 81% | |
| Micropep | 81% | |
| Terramera | 78% |
Ascribe Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 14, 2025 | ||||
| Corporate Funding | Jan 29, 2025 | ||||
| Grant | Nov 17, 2021 |
Ascribe Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Center for Regional Economic Advancement | Grant |
| Cultivation Capital | Series A |
| ICIG Ventures | Corporate Funding |
| Ponderosa Ventures | Grant |
| Acre Venture Partners | Series A, Grant |
| Syngenta Group Ventures | Series A |
| Trailhead Capital | Series A, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 94% MoM.
- Oct 14, 2025
$12M round completed.
Ascribe Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ascribe Bio's valuation, stock price, and market status.
Is Ascribe Bio a public or private company?
Ascribe Bio is a private company.
What is the current stock price of Ascribe Bio?
Ascribe Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Ascribe Bio worth (valuation)?
Valuation information for Ascribe Bio is not publicly available.
Can I buy Ascribe Bio stock?
Ascribe Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ascribe Bio's last funding round?
Ascribe Bio's most recent funding round was Series A on October 14, 2025.
Who are the main investors in Ascribe Bio?
Key investors in Ascribe Bio include Acre Venture Partners, The Yield Lab.
Will Ascribe Bio IPO soon?
No public IPO plans have been announced for Ascribe Bio.
How can I track Ascribe Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ascribe Bio's secondary market activity and sign up for updates.